Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mesenchymal Stem Cells for the Treatment of MS

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00781872
First received: October 28, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):